Brawn Biotech

{
  "main_header": {
    "sid": 479596,
    "name": "Brawn Biotech",
    "stock_name": "Brawn Biotech",
    "full_name": "Brawn Biotech Ltd",
    "name_url": "stocks-analysis/brawn-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "20.21",
    "chg": 0.96,
    "chgp": "4.99%",
    "dir": 1,
    "prev_price": "19.25",
    "mcapval": "6.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530207,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE899B01015",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "2.41 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/brawn-biotech-479596-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Brawn Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brawn-biotech-ltd-is-rated-sell-3771488",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BrawnBiotechLtd_mojoScore_3771488.png",
        "date": "2025-12-26 21:51:48",
        "description": "Brawn Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Dec 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Brawn Biotech Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brawn-biotech-stock-downgraded-to-sell-amid-mixed-technicals-and-weak-fundamentals-3754646",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BrawnBiotech_mojoScore_3754646.png",
        "date": "2025-12-10 08:04:09",
        "description": "Brawn Biotech, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in market assessment driven by a combination of technical indicators and fundamental financial data. While the company’s recent quarterly results reflect a flat performance, evolving technical trends and valuation considerations have influenced the overall analytical perspective on the stock."
      },
      {
        "title": "Brawn Biotech Sees Extraordinary Buying Interest Amid Upper Circuit Scenario",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brawn-biotech-hits-upper-circuit-amidst-unprecedented-buying-interest-3749195",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BrawnBiotech_only_buyers_3749195.png",
        "date": "2025-12-05 15:35:22",
        "description": "Brawn Biotech has attracted remarkable buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This unusual market activity signals a potential multi-day circuit scenario, underscoring strong demand despite recent underperformance against broader benchmarks."
      },
      {
        "title": "Brawn Biotech Surges to Upper Circuit Amid Unprecedented Buying Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brawn-biotech-hits-upper-circuit-amid-unprecedented-buying-interest-3746840",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BrawnBiotech_only_buyers_3746840.png",
        "date": "2025-12-04 13:40:29",
        "description": "Brawn Biotech has witnessed extraordinary buying momentum today, hitting the upper circuit with a queue of only buy orders and no sellers in sight. This rare market phenomenon signals intense investor enthusiasm and raises the possibility of a multi-day circuit scenario for the pharmaceutical and biotechnology company."
      },
      {
        "title": "Brawn Biotech Sees Unprecedented Buying Interest Amid Upper Circuit Scenario",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brawn-biotech-hits-upper-circuit-amid-unprecedented-buying-interest-3744278",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BrawnBiotech_only_buyers_3744278.png",
        "date": "2025-12-03 12:31:08",
        "description": "Brawn Biotech has attracted extraordinary buying interest today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals a strong demand surge, potentially setting the stage for a multi-day circuit scenario as sellers remain absent from the order book."
      },
      {
        "title": "Brawn Biotech Evaluation Metrics Reflect Mixed Signals Amidst Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brawn-biotech-downgraded-to-strong-sell-amid-technical-and-fundamental-weaknesses-3737476",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BrawnBiotech_mojoScore_3737476.png",
        "date": "2025-12-01 08:02:15",
        "description": "Brawn Biotech’s recent assessment reveals a complex picture shaped by flat quarterly financials, subdued long-term growth, and a shift in technical indicators. The pharmaceutical and biotechnology company’s current market performance and fundamental metrics highlight challenges amid a sideways technical trend, prompting a revision in the company’s evaluation across quality, valuation, financial trend, and technical parameters."
      },
      {
        "title": "How has been the historical performance of Brawn Biotech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-brawn-biotech-3735981",
        "imagepath": "",
        "date": "2025-11-28 22:36:57",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Trends</strong></p>\n<p>In the fiscal year ending March 2023, Brawn Biotech reported consolidated net sales of ₹0.48 crore, with no other operating income contributing to total operating income. The company’s expenditure closely matched its operating income, resulting in an operating profit margin excluding other income of 0.0%. However, other income of ₹0.24 crore helped the company achieve an operating profit (PBDIT) of ₹0.24 crore. After accounting for depreciation and taxes, the consolidated net profit stood at ₹0.19 crore, translating to a profit after tax (PAT) margin of 39.58%. Earnings per share (EPS) for the same period were ₹0.39, reflecting modest profitability relative to equity capital.</p>\n<p>Despite low sales figures, the company managed to maintain a ..."
      },
      {
        "title": "Brawn Biotech Sees Unprecedented Buying Interest Amid Upper Circuit Scenario",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brawn-biotech-hits-upper-circuit-amid-unprecedented-buying-interest-3733430",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BrawnBiotech_only_buyers_3733430.png",
        "date": "2025-11-27 10:40:27",
        "description": "Brawn Biotech has captured market attention with extraordinary buying interest, registering an upper circuit with exclusively buy orders in the queue. This rare phenomenon highlights a potential multi-day circuit scenario, underscoring the stock’s unique position in the Pharmaceuticals & Biotechnology sector despite mixed performance trends over various time frames."
      },
      {
        "title": "Brawn Biotech Faces Intense Selling Pressure Amidst Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brawn-biotech-plunges-on-extreme-selling-pressure-amid-market-underperformance-3731414",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BrawnBiotech_only_sellers_3731414.png",
        "date": "2025-11-26 12:30:28",
        "description": "Brawn Biotech Ltd has encountered significant selling pressure today, with the stock hitting its lower circuit and registering only sell orders in the queue. This extreme selling activity signals distress among investors, as the stock trades sharply below key moving averages and continues a pattern of underperformance relative to the broader market and its sector peers."
      }
    ],
    "total": 413,
    "sid": "479596",
    "stock_news_url": "https://www.marketsmojo.com/news/brawn-biotech-479596"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "30-Jan-2026",
      "details": "Appointment of Chief Financial Officer.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Jan-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)",
      "datetime": "05-Jan-2026",
      "details": "Resignation of Ms. Pooja Pandey (CFO and KMP).",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Brawn Biotech Ltd has declared <strong>10%</strong> dividend, ex-date: 12 Sep 18",
          "dt": "2018-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Brawn Biotech Ltd is Rated Sell

2025-12-26 21:51:48

Brawn Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Dec 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Brawn Biotech Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals

2025-12-10 08:04:09

Brawn Biotech, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in market assessment driven by a combination of technical indicators and fundamental financial data. While the company’s recent quarterly results reflect a flat performance, evolving technical trends and valuation considerations have influenced the overall analytical perspective on the stock.

Read full news article

Brawn Biotech Sees Extraordinary Buying Interest Amid Upper Circuit Scenario

2025-12-05 15:35:22

Brawn Biotech has attracted remarkable buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This unusual market activity signals a potential multi-day circuit scenario, underscoring strong demand despite recent underperformance against broader benchmarks.

Read full news article

Brawn Biotech Surges to Upper Circuit Amid Unprecedented Buying Interest

2025-12-04 13:40:29

Brawn Biotech has witnessed extraordinary buying momentum today, hitting the upper circuit with a queue of only buy orders and no sellers in sight. This rare market phenomenon signals intense investor enthusiasm and raises the possibility of a multi-day circuit scenario for the pharmaceutical and biotechnology company.

Read full news article

Brawn Biotech Sees Unprecedented Buying Interest Amid Upper Circuit Scenario

2025-12-03 12:31:08

Brawn Biotech has attracted extraordinary buying interest today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals a strong demand surge, potentially setting the stage for a multi-day circuit scenario as sellers remain absent from the order book.

Read full news article

Brawn Biotech Evaluation Metrics Reflect Mixed Signals Amidst Flat Financials

2025-12-01 08:02:15

Brawn Biotech’s recent assessment reveals a complex picture shaped by flat quarterly financials, subdued long-term growth, and a shift in technical indicators. The pharmaceutical and biotechnology company’s current market performance and fundamental metrics highlight challenges amid a sideways technical trend, prompting a revision in the company’s evaluation across quality, valuation, financial trend, and technical parameters.

Read full news article

How has been the historical performance of Brawn Biotech?

2025-11-28 22:36:57

Revenue and Profitability Trends

In the fiscal year ending March 2023, Brawn Biotech reported consolidated net sales of ₹0.48 crore, with no other operating income contributing to total operating income. The company’s expenditure closely matched its operating income, resulting in an operating profit margin excluding other income of 0.0%. However, other income of ₹0.24 crore helped the company achieve an operating profit (PBDIT) of ₹0.24 crore. After accounting for depreciation and taxes, the consolidated net profit stood at ₹0.19 crore, translating to a profit after tax (PAT) margin of 39.58%. Earnings per share (EPS) for the same period were ₹0.39, reflecting modest profitability relative to equity capital.

Despite low sales figures, the company managed to maintain a ...

Read full news article

Brawn Biotech Sees Unprecedented Buying Interest Amid Upper Circuit Scenario

2025-11-27 10:40:27

Brawn Biotech has captured market attention with extraordinary buying interest, registering an upper circuit with exclusively buy orders in the queue. This rare phenomenon highlights a potential multi-day circuit scenario, underscoring the stock’s unique position in the Pharmaceuticals & Biotechnology sector despite mixed performance trends over various time frames.

Read full news article

Brawn Biotech Faces Intense Selling Pressure Amidst Consecutive Losses

2025-11-26 12:30:28

Brawn Biotech Ltd has encountered significant selling pressure today, with the stock hitting its lower circuit and registering only sell orders in the queue. This extreme selling activity signals distress among investors, as the stock trades sharply below key moving averages and continues a pattern of underperformance relative to the broader market and its sector peers.

Read full news article

View All News